Trinity Biotech (TRIB) Free Cash Flow Growth (1y) (2010 - 2024)
Trinity Biotech (TRIB) Free Cash Flow Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 9.73% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | -109.40% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 363.84% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 108.16% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 133.09% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 29.12% |
| 10 | Trinity Biotech | 27,300.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 567.86% |
| Jun 30, 2024 | 45.07% |
| Mar 31, 2024 | 47.39% |
| Dec 31, 2023 | -79.72% |
| Sep 30, 2023 | -60.12% |
| Jun 30, 2023 | -4,985,201.40% |
| Dec 31, 2022 | -38.35% |
| Jun 30, 2022 | -63.24% |
| Sep 30, 2010 | -5.31% |
| Jun 30, 2010 | -41.09% |
| Mar 31, 2010 | -7.08% |